Bergamaschini Luigi Cesare

PROFESSORE ASSOCIATO CONFERMATO
SSD
MED/09 - MEDICINA INTERNA
Settore concorsuale
06/B1 - MEDICINA INTERNA

Contatti

Sede di lavoro

Via Marostica, 8

Altri numeri di telefono
02-40297708
E-mail di ateneo
Ricevimento
previo appuntamento da concordare via e-mail
Luogo di ricevimento
Pio Albergo trivulzio, Reparto Ronzoni

Didattica

Ricerca

Pubblicazioni
  • Use of the Frailty Index in Older Persons with Chronic Kidney Disease / C. Vezza, S. Vettoretti, L. Caldiroli, L. Bergamaschini, P. Messa, M. Cesari. - In: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. - ISSN 1525-8610. - (2019 Jun 05). [Epub ahead of print]
  • Current and emerging biologics for the treatment of hereditary angioedema / F. Perego, M.A. Wu, A. Valerieva, S. Caccia, C. Suffritti, A. Zanichelli, L. Bergamaschini, M. Cicardi. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - 19:6(2019 Mar 26), pp. 517-526.
  • Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation / R. Castelli, P. Gallipoli, R. Schiavon, T. Teatini, G.L. Deliliers, L. Bergamaschini. - In: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. - ISSN 0929-5305. - 47:1(2019 Jan), pp. 155-156.
  • First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas / R. Castelli, L.C. Bergamaschini, G.L. Deliliers. - In: MEDICAL ONCOLOGY. - ISSN 1357-0560. - 35:2(2018 Feb), pp. 15.1-15.7.
  • High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation / R. Castelli, P. Gallipoli, R. Schiavon, T. Teatini, G.L. Deliliers, L.C. Bergamaschini. - In: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. - ISSN 0929-5305. - 45:1(2018 Jan), pp. 106-113.